Empagliflozin 10mg Tablet
Reviewed educational reference: what Empagliflozin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Empagliflozin
- Strength
- 10mg
- Dosage form
- Tablet
- Drug class
- SGLT2 Inhibitor
Related products
No reviewed products are currently published for this generic.
Empagliflozin 10mg Tablet is a medication containing Empagliflozin, which belongs to a class of drugs called SGLT2 inhibitors. It is primarily used to help adults with type 2 diabetes manage their blood sugar levels. Unlike many other diabetes medications, Empagliflozin does not rely on the pancreas to produce insulin. Instead, it works directly on the kidneys to remove excess glucose from the blood through the urine. This action not only lowers blood glucose but also provides additional benefits for the heart and kidneys, making it a versatile tool in modern metabolic care.
At a glance
Empagliflozin 10mg Tablet is a prescription tablet containing 10mg of Empagliflozin.
It lowers blood sugar by preventing the kidneys from reabsorbing glucose.
It is used to manage type 2 diabetes and protect the heart and kidneys.
Uses of Empagliflozin
- Management of Type 2 Diabetes Mellitus to improve glycemic control.
- Reduction of the risk of cardiovascular death in adults with type 2 diabetes and heart disease.
- Treatment of heart failure to reduce the risk of hospitalization.
- Slowing the progression of Chronic Kidney Disease (CKD) in eligible patients.
- Reduction of systolic blood pressure as a secondary effect of glucose loss.
- Assistance in modest weight reduction for patients with obesity and diabetes.
Benefits of Empagliflozin
Cardiovascular and Renal Protection
Empagliflozin 10mg Tablet provides benefits that go beyond blood sugar control. It significantly reduces the risk of heart failure hospitalization and cardiovascular death. For patients with chronic kidney disease, Empagliflozin helps slow the decline of kidney function, which is a major advantage over older diabetes drugs.
Weight and Pressure Management
Because Empagliflozin causes the body to excrete glucose and sodium through the urine, many patients experience a modest drop in body weight. This process also helps in lowering blood pressure, which reduces the overall strain on the heart and blood vessels.
Side effects of Empagliflozin
The most common side effects of Empagliflozin 10mg Tablet are related to the increase in sugar in the urine. This creates an environment where yeast and bacteria can grow, leading to genital mycotic infections or urinary tract infections. Some patients may experience increased urination, which can lead to dehydration or a drop in blood pressure, causing dizziness. A rare but serious side effect is euglycemic ketoacidosis, where the blood becomes acidic even though blood sugar levels appear normal. Other possible effects include nausea, thirst, and a general feeling of weakness due to volume depletion.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Genital mycotic infection | Very common | Mild | Maintain strict genital hygiene. |
| Urinary tract infection | Common | Moderate | Increase daily fluid intake. |
| Volume depletion | Common | Moderate | Reduce dose of other diuretics. |
How to manage side effects
Genital mycotic infection
- Clean area daily
- Use antifungal cream
- Consult doctor if persistent
Urinary tract infection
- Drink more water
- Complete antibiotic course
- Monitor for fever
Volume depletion
- Monitor weight
- Increase water intake
- Report dizziness
How to use Empagliflozin
- Take Empagliflozin 10mg Tablet once daily, preferably at the same time each morning.
- You may take the tablet with or without food.
- Swallow the tablet whole with a glass of water. Do not crush or chew it.
- If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take two doses at once.
Special population advice
Kidney impairment
- Not recommended for glycemic control if eGFR is below 30 mL/min/1.73m2.
- Monitor eGFR every 3 to 6 months.
Liver impairment
- No dose adjustment is needed for patients with hepatic impairment.
Children
- Safety and efficacy in patients under 18 years of age have not been established.
Elderly
- Use with caution as elderly patients are more prone to dehydration and hypotension.
- Monitor blood pressure and fluid status closely.
How Empagliflozin works
Empagliflozin works by blocking the SGLT2 protein in the proximal tubules of the kidneys. Normally, this protein reabsorbs glucose back into the bloodstream. By inhibiting this process, Empagliflozin 10mg Tablet forces the kidneys to excrete excess glucose through the urine. This lowers the overall blood glucose level without increasing insulin secretion, which also reduces the risk of hypoglycemia when used alone.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Empagliflozin 10mg Tablet, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular schedule. Do not take a double dose to make up for a forgotten tablet.
In case of overdose
An overdose of Empagliflozin 10mg Tablet may lead to severe dehydration, low blood pressure, and an increased risk of ketoacidosis. Symptoms may include extreme thirst, confusion, and rapid breathing. Immediate medical attention is required to manage fluid balance and monitor blood glucose and ketone levels.
Treatment is supportive and symptomatic.
- Initial Action
- Assess airway, breathing, and circulation to ensure stability.
- Fluid Management
- Administer intravenous fluids to correct dehydration and volume depletion.
- Glucose Monitoring
- Monitor blood glucose levels closely to detect hypoglycemia or euglycemic ketoacidosis.
- Electrolyte Correction
- Correct any imbalances in potassium or sodium caused by osmotic diuresis.
Safety and precautions
When to avoid Empagliflozin
- Hypersensitivity
Severe allergic reaction to Empagliflozin or any tablet excipients.
- Severe Renal Failure
Not recommended if eGFR is below 20 mL/min/1.73m2.
- History of DKA
Increased risk of euglycemic ketoacidosis, especially during illness.
- Volume depletion
Risk of hypotension and acute kidney injury in dehydrated patients.
- Urinary tract infections
Higher incidence of recurrent UTIs in predisposed individuals.
- Concurrent diuretic use
Potential for excessive fluid loss and severe hypotension.
Safety at a glance
Limit alcohol intake as it can increase the risk of dehydration and ketoacidosis.
Do not use during pregnancy due to lack of safety data and potential fetal harm.
Avoid use during breastfeeding as it is unknown if the drug passes into breast milk.
Generally safe, but be cautious if you feel dizzy due to low blood pressure.
Monitor eGFR regularly. Dose adjustment or discontinuation may be needed if kidney function drops.
No dose adjustment is typically required for patients with liver impairment.
Do not take if you have a known hypersensitivity to Empagliflozin.
Not approved for use in children or adolescents under 18 years of age.
Use with care as elderly patients are more susceptible to dehydration and hypotension.
Interactions
With other medicines
Insulin
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Reduce the dose of insulin as needed.
Loop Diuretics
ModerateChanges the medicine’s effect
What can happen: Increased risk of volume depletion and hypotension.
What to do: Adjust diuretic dose and monitor fluid status.
Sulfonylureas
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Reduce the dose of the sulfonylurea.
With food and drink
- High sugar foodsModerate
Excessive intake of simple sugars reduces the efficacy of blood glucose lowering.
- AlcoholModerate
Alcohol consumption can exacerbate the risk of dehydration and ketoacidosis.
If you have another condition
- Severe Renal Impairment
Reduced efficacy for glucose lowering and increased risk of adverse events.
- Type 1 Diabetes
High risk of euglycemic ketoacidosis, which can be life threatening.
- Liver Cirrhosis
Use with caution due to potential for volume depletion and hypotension.
Effect on laboratory tests
- Urine Glucose
Increased
Empagliflozin causes glucosuria, making urine glucose tests positive even if blood glucose is normal.
Quick tips
- Drink plenty of water throughout the day to prevent dehydration and urinary tract infections.
- Maintain strict genital hygiene to reduce the risk of fungal infections.
- Monitor your blood sugar levels regularly as directed by your doctor.
- Inform your healthcare provider if you are planning a surgery or a medical procedure requiring fasting.
Counselling points
- HydrationImportant
Drink plenty of water to prevent dehydration and UTIs.
- HygieneImportant
Keep the genital area clean and dry to avoid fungal infections.
- Sick Day RulesGood to know
Stop taking the drug if you are severely ill or cannot eat.
- Foot CareGood to know
Check your feet daily for any sores or redness.
Monitoring during treatment
Before starting
- Serum creatinine
- eGFR
- Urine albumin-to-creatinine ratio
- Blood pressure
During treatment
- every 6 months: Repeat eGFR and serum creatinine tests
What is being watched
- eGFR
- Blood glucose
- Blood pressure
- Weight
Pharmacokinetics
- Absorption
- Rapidly absorbed after oral administration.
- Bioavailability
- Approximately 60%
- Protein binding
- 86%
- Volume of distribution
- Not established
- Half-life
- 12.4 hours
- Metabolism
- Primarily via glucuronidation by UGT enzymes.
- Excretion
- 54% excreted in urine and 41% in feces.
- Onset / duration
- Onset is rapid with a duration of action lasting 24 hours.
Fact box
- Chemical class
- C-glycoside
- Habit forming
- No
- Therapeutic class
- Antidiabetic
- Action class
- Sodium-Glucose Co-transporter 2 Inhibitor
- Storage
- Store Empagliflozin 10mg Tablet at room temperature, away from moisture and direct sunlight. Keep it out of reach of children.
- ATC code
- A10BK29
- Pregnancy category
- C
More information
The Shift to Organ Protection
For decades, the primary goal of treating type 2 diabetes was simply to lower the HbA1c level. However, the introduction of Empagliflozin marked a shift toward organ protection. Clinical trials showed that this drug does more than just lower glucose. It provides a significant reduction in the risk of death from cardiovascular causes and prevents the worsening of heart failure. Clinicians now often prescribe Empagliflozin 10mg Tablet not just for its glucose lowering effect, but as a protective therapy for the heart and kidneys. This makes it a first line choice for patients who have a history of heart disease or chronic kidney disease, regardless of their baseline HbA1c.
Comparing SGLT2 Inhibitors
Empagliflozin is one of several SGLT2 inhibitors, including dapagliflozin and canagliflozin. While all these drugs work by blocking glucose reabsorption in the kidney, Empagliflozin has some of the strongest evidence for reducing cardiovascular death. Some clinicians prefer Empagliflozin 10mg Tablet because of the robust data from the EMPA-REG OUTCOME trial. While the differences in glucose lowering are modest between the drugs, the specific benefits for heart failure and kidney protection vary slightly. The choice between these agents often depends on the patient's specific comorbidities, such as the presence of heart failure with reduced ejection fraction.
Lifestyle and Dietary Synergy
Taking Empagliflozin 10mg Tablet requires certain lifestyle adjustments to maximize safety. Because the drug increases the amount of sugar in the urine, it creates a risk for fungal infections. Patients are advised to maintain meticulous genital hygiene. Furthermore, the diuretic effect of Empagliflozin means that water intake must be increased. A low carbohydrate diet complements the action of the drug, as it reduces the overall glucose load the kidneys must handle. Patients should also be taught about sick day rules, which involve pausing the medication during severe illness or fasting to prevent the onset of euglycemic ketoacidosis.
Patient Journey and Expectations
When starting Empagliflozin 10mg Tablet, patients should expect a few changes in the first few weeks. The most immediate effect is often an increase in the frequency of urination. This is a sign that the drug is working to remove glucose from the body. Over the first few months, patients typically see a gradual decline in their HbA1c and a modest reduction in weight. It is important to manage expectations, as this drug is not a rapid weight loss agent but a metabolic regulator. Long term success depends on combining the medication with a healthy diet and regular physical activity to maintain cardiovascular health.
References
- Electronic Medicines Compendium. Empagliflozin 10 mg tablets, Summary of Product Characteristics.View sourceAccessed
- European Medicines Agency. Jardiance product information.View sourceAccessed
- Rwanda FDA. Jardiance 10mg Tablets SmPC.View sourceAccessed
- Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. McGraw-Hill.Accessed
- Katzung B. Basic and Clinical Pharmacology. 14th ed. McGraw-Hill.Accessed
Frequently asked questions about Empagliflozin
Will this medicine cause me to urinate more?
Yes, because Empagliflozin removes sugar through the urine, you may notice an increase in urination, especially at the start of treatment.
Can I take Empagliflozin 10mg Tablet if I have Type 1 Diabetes?
No, this medication is specifically indicated for Type 2 Diabetes. Using it in Type 1 Diabetes increases the risk of a serious condition called ketoacidosis.
Does Empagliflozin 10mg Tablet cause low blood sugar (hypoglycemia)?
When used alone, it rarely causes hypoglycemia. However, if you take it with insulin or sulfonylureas, the risk increases.
What should I do if I get a yeast infection?
Contact your doctor. Genital fungal infections are common with SGLT2 inhibitors and are usually treated with antifungal creams.
Can I stop taking this drug if my sugar levels become normal?
Do not stop taking Empagliflozin 10mg Tablet without consulting your doctor, as your blood sugar may rise again.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →